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MOLECULAR ANALYSIS OF AXIN2 AS A MARKER FOR IDENTIFYING 
TENDON PROGENITOR CELLS 
JOSHUA SOLOMON GREEN 
ABSTRACT 
Tendons are robust structures, made of cellular and extracellular components, that 
transmit force efficiently between muscle and bone that is essential for permitting 
strength and mobility in vertebrates.  Although the tendon is mainly comprised of 
extracellular matrix, resident tendon cells – tenoblasts and tenocytes –  have been 
established as responsible for constructing the fibrotic structure of the tendon during 
development.  
Various forms of tendinopathy impact a broad demographic range, yet effective 
treatment modalities remain rather limited due to our lack of understanding of the 
molecular mechanisms that drive tendon healing, which has made this a critical area of 
tendon research. Recently, the presence of a stem cell/progenitor-like tendon cell 
population within the tendon was identified, implicating their potential role in tendon 
regeneration and providing course for further research on this novel tendon cell 
population  (Bi et al., 2007) .  
Several genetic markers, such as Scleraxis (Scx), collagen type I (Col I)  and 
Mohawk (Mkx), have been shown to trace the tendon cell lineage (Edom‐Vovard & 
Duprez, 2004; Ito et al., 2010; Schweitzer et al., 2001). However, they do not provide 
specificity towards these tendon-derived stem cell/progenitor cells (TSPCs), nor do they 
give much insight into the interactions between the resident cells that govern tendon 
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biology.  Through the use of an Axin2 marker,  previous stem cell research has suggested 
the Wnt/β-Catenin signaling pathway to be involved in regulating the self-renewing 
capacity of these cells within the intestine, liver, epidermis and brain (Bowman, van 
Amerongen, Palmer, & Nusse, 2013; Lim et al., 2013; Wang, Zhao, Fish, Logan, & 
Nusse, 2015). Therefore, this study aims to  apply the Axin2 marker to the previously 
identified TSPC population to illustrate the heterogeneity of these cells and implicate that 
their proliferative potential is controlled through Wnt/β-Catenin signaling.  
By using an Axin2-CreERt2;Rosa-LSLTdTomato mouse model in an injured 
state, due to the disruption of the tendon matrix during TSPC isolation, we have 
demonstrated through RT-qPCR analysis that there are differences in gene expression 
between Axin2+/- cells, particularly in Mkx and Col II. Furthermore, we utilized cell 
counting and FACS analysis to show that the Axin2+  cells have a greater propensity to 
proliferate than Axin2- cells. Our findings suggest that the Wnt/β-Catenin pathway is 
involved in regulating tendon cell fate and may be an underlying mechanism behind 
tendon repair.
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INTRODUCTION 
Various Pathologies of Tendons & Tendon Healing 
 Tendinopathies and tendon tears are common musculoskeletal injuries that 
account for over 30% of all musculoskeletal-related medical consultations and impact a 
wide demographic of people, from professional athletes to the elderly (Andarawis‐Puri, 
Flatow, & Soslowsky, 2015). Tendon injuries may present as either acute or chronic and 
are caused by various intrinsic factors (age, gender, biomechanics) and extrinsic factors, 
such as the physical stress placed on the tendon (Rees, Wilson, & Wolman, 2006). 
Chronic injuries tend to be due to overuse and aging, while acute injuries are typically as 
a result of trauma or rupture (Grinstein & Galloway, 2018).  
In chronic tendon disorders, it is common for there to be an interplay between 
intrinsic and extrinsic factors. For instance, Achilles tendinopathy is commonly due to 
structural and mechanical irregularities, such as hyper-pronation of the foot, in 
conjunction with excessive loading during physical training and aging (Sharma & 
Maffulli, 2006).  The etiology of tendinopathy remains uncertain, but several biological 
processes appear to be involved in some capacity, such as hypoxia, ischemia, oxidative 
stress, impaired apoptosis and inflammatory mediators, among several others (Sharma & 
Maffulli, 2006).  
Following an acute injury, tendons undergo a three-stage process of healing. First, 
in the inflammatory phase, neutrophils, monocytes and macrophages enter the tendon to 
remove necrotic cells, tendon cells are recruited to site to begin synthesizing extracellular 
matrix (ECM) components, and angiogenic factors initiate the formation of new 
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vasculature. Next, in the proliferative phase, tendon cells continue to deposit collagen and 
other ECM components. Lastly, the remodeling phase is characterized by the synthesis of 
collagen and GAGs, activity of matrix-degrading enzymes and decrease in cellularity as 
the tendon becomes more fibrous (Grinstein & Galloway, 2018). 
Despite the broad impact of tendon related injuries and disorders, current 
treatment is rather limited and often resorts to surgery and physical therapy, which render 
varying degrees of success in alleviating symptoms. For example, small and large rotator 
cuff ruptures have a re-tear rate of up to 35% and 94%, respectively, after surgical 
intervention. (Andarawis‐Puri et al., 2015). Consequently, the lack of effective treatment 
modalities makes tendinopathies an attractive target for developing stem cell mediated 
therapies. However, general understanding of the molecular processes and cell 
populations that dictate tendon healing is incomplete. Uncovering the regulatory 
mechanisms of tendon development and regeneration may enable breakthroughs in 
treatment for tendinopathy in the near future, which would make a significant impact on 
the populations affected. 
 
Tendon Function and Structure 
 Tendons are predominantly fibrotic structures that are interposed between 
muscles and bones in order to transmit tremendous force efficiently between the two and 
enable joint movement. Tendons can experience loads up to 9 kN, which amounts to 
more than ten times the body weight of the average person (Grinstein & Galloway, 2018). 
The connecting point between muscle and tendon is referred to the myotendinous 
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junction (MTJ), while the connecting point between bone and tendon is referred to as the 
osteotendinous junction (OTJ). Furthermore, the attachment site of the proximal tendon 
to muscle is known as the muscle origin, and the attachment of the distal tendon to bone 
is known as an insertion. A healthy tendon is typically white in color and varies in shape, 
ranging from cylindrical, fan-shaped or ribbon-shaped. Muscles designed to generate 
greater force, such as biceps and triceps, have broader and shorter tendons, while those 
that carry out finer movement, such as flexors and extensors, have longer and thinner 
tendons (Kannus, 2000).  
 Tendons are highly organized structures that have several extra-tendinous features 
to facilitate their function and minimize friction. Fibrous sheaths (or retinacula) are 
canals that guide tendon movement. Reflection pulleys reinforce the fibrous sheaths and 
ensure the tendon remains on its track. Meanwhile, synovial sheaths provide access 
points for tendons to attach to bone or muscle. Some tendons, such as the Achilles, do not 
have a true synovial sheath. Instead, these tendons have a peritendinous sheath (or 
paratenon), which is an elastic sleeve that permits tendon movement. Lastly, the tendon 
bursae are located at sites where bony prominences may compress the tendon in order to 
reduce friction (Kannus, 2000). 
 Microscopically, the tendon is composed of a highly organized network of 
collagen fibers and elastin within a proteoglycan-water matrix. Collagen (primarily type 
I) accounts for about 65-80% and elastin about 1-2% of the dry mass of the tendon 
(Kannus, 2000). Type I collagen peptides arrange into a triple helical rod-shaped fiber, 
called a tropocollagen, which crosslink with other one another to form collagen fibrils. 
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These fibrils aggregate further into collagen fibers, which are considered to be the basic 
unit of the tendon (Kannus, 2000). 
The tendon is composed of a hierarchal arrangement of collagen fibers: primary 
(subfascicles), secondary (fascicles) and tertiary bundles (Sharma & Maffulli, 2006) . 
These bundles are surrounded by a fine sheath of connective tissue, known as the 
endotenon, which houses blood vessels, nerves and lymphocytes of the tendon (Benjamin 
& Ralphs, 2000). The endotenon and tertiary bundles are encapsulated within another 
connective tissue structure, known as the epitenon (Figure 1.1). As mentioned earlier, 
some tendons, such as the Achilles, have a paratenon attached to the outside of the 
epitenon, instead of having a true synovial sheath. The paratenon occupies the space 
between the tendon and its attachment sites to bone and muscle to minimize friction 
during movement (Kannus, 2000). 
 
Figure 1.1: Arrangement of Collagen Fibers within the Tendon  
  5
(taken from “Tendon | anatomy,” n.d.) 
 
 
Although 95% of tendon collagen is of type I, several other types are involved in 
the fibrillar network within the tendon, such as types II, III, V, VI, IX, X, XI, XII, XIV 
collagen (Screen, Berk, Kadler, Ramirez, & Young, 2015; Sharma & Maffulli, 2006). 
Prior research suggests that each collagen type appears to serve a unique role in 
fibrillogenesis within the tendon. As such, type II, IX and X collagen have been found to 
be expressed at bone insertion sites, implicating their important involvement in the 
fibrocartilage transition to bone (Thomopoulos et al., 2002). Type III collagen has been 
shown to play a role in fibril assembly in the embryo, while restricting the growth of 
collagen type I fibrils during later stages of development (Birk & Mayne, 1997; G. Zhang 
et al., 2005). Type V and XI collagen are considered fibril-forming collagens that 
facilitate formation of nucleation sites (Wenstrup et al., 2011). Meanwhile type VI 
collagen is found in the pericullar matrix of the tendon and appears to unite several 
tendon cells into a linear array (Ritty, Roth, & Heuser, 2003). Lastly, type XII and XIV 
collagen are considered FACITs due to their interrupted triple helices, which enable them 
to further integrate collagen fibers into fascicles through crosslinking and associating 
with other ECM components. Specifically, type XII collagen can bind the proteoglycans 
decorin (Dcn) and fibromodulin (Fbmd) and type I collagen to aide in fibrillogenesis (G. 
Zhang et al., 2005). 
 Within the fibrillar network are several other ECM proteins, mainly 
proteoglycans, glycoproteins, glycosaminoglycans (GAGs) and other smaller molecules. 
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Proteoglycans are glycosylated proteins that contain highly anionic GAGs, which equip it 
with hydrophilic properties crucial to its biophysiological function. Due its dense 
negative charge, proteoglycans are able to provide a viscous, aqueous environment that 
allows for water-soluble molecules to diffuse, resident cells to migrate and collagen 
fibers to slide with minimal friction, while allowing them to withstand great tensile force. 
A subset of small leucine-rich proteoglycans (SLRPs) – Fbmd, biglycan (Bgn), Dcn and 
lumicans – appear within the tendon and play a role in regulating collagen fibrillogenesis 
and maintaining the tendon cell niche (Bi et al., 2007; Ezura, Chakravarti, Oldberg, 
Chervoneva, & Birk, 2000). Additionally, the glycoproteins fibronectin and 
thrombospondin are involved in the regeneration and repair process of the tendon, while 
tenascin C may facilitate collagen fiber orientation and alignment (Sharma & Maffulli, 
2006). 
 The hydrophilic environment created by proteoglycans permits survival and 
functionality of the cells of the tendon, the tenoblasts and tenocytes, which reside within 
the network of ECM. Tenoblasts are considered to be the immature form of tendon cells. 
They contain a more rounded, spindle-shaped morphology and have a higher cytoplasmic 
organelle content, which is indicative of their higher metabolic activity. Eventually, 
tenoblasts begin to elongate and transform into a stellate morphology as they mature into 
tenocytes. Contrastingly, the tenocyte appears to have a lower nucleus to cytoplasm ratio, 
meaning it has a relatively lower metabolic activity. Nevertheless, mature tenocytes are 
responsible for synthesizing collagen and all other components of the tendon ECM, while 
also contributing to energy generation (Sharma & Maffulli, 2006).                                                                                                                            
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Tendon Embryology and Development 
 There are three distinct classes of tendons – cranial, axial and appendicular – with 
different embryological origins (Figure 1.2). Prior research has determined that cranial 
tendons, along with the rest of the cranial skeletal tissue, are derived from neural crest 
cells (Chen & Galloway, 2014; Debbache, Parfejevs, & Sommer, 2018). Contrastingly, 
axial tendons arise from the paraxial mesoderm, or somite. After the somite differentiates 
into the dermatome (dermal progenitors), myotome (myogenic progenitors), and 
sclerotome (skeletogenic and chondrogenic progenitors), a specialized compartment 
forms from the sclerotome, called the syndetome, which contains the tendon progenitors. 
The syndetome rests between and interacts with the sclerotome and myotome to form 
anatomically functional axial tendon (Brent, Schweitzer, & Tabin, 2003). 
Expression of Scx, a basic helix-loop-helix transcription factor now regarded as 
the earliest marker for tendon progenitors, has been found to be highly expressed within 
the syndetome during its formation (Brent et al., 2003). Previous studies have suggested 
that myogenic tissue is important to initiate Scx expression in the syndetome (Brent & 
Tabin, 2004). Additionally, the fibroblast growth factors, FGF4 and FGF8, were found to 
stimulate Scx expression in the syndetome through the mitogen-activated protein kinase 
(MAPK) pathway and activation of Ets transcription factors in tendon progenitors (Brent 
& Tabin, 2004). Unlike the myotome, the sclerotome appears to have an inhibitory role in 
axial tendon formation that is moderated through the expression of the paired-box protein 
Pax1 and SRY-box proteins Sox5/6 (Brent, Braun, & Tabin, 2005). 
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Meanwhile, appendicular tendon primordia emanate from the subectodermal limb 
bud mesenchyme, which is derived from the lateral plate mesoderm (LPM). Similar to 
the axial tendon progenitors, appendicular tendon primordia align between respective 
muscle and cartilage where they develop into mature tendons (Schweitzer et al., 2001). 
While myogenic cells appear to be critical for inducing axial tendon progenitors, research 
has shown that they are involved in maintenance, differentiation and maturation in limb 
tendon progenitors (Huang, Lu, & Schweitzer, 2015). Similar to axial tendons, respective 
skeletal tissue confers an inhibitory response to tendon formation that is mediated by 
bone morphogenic protein (BMP) signaling to downregulate Scx (Schweitzer et al., 
2001). Furthermore, the molecular regulation of limb tendon formation appears to depend 
on the anatomical location of the tendon; for, more proximal limb tendons do not require 
Sox9 for formation, but do rely on muscle for differentiation and individuation, and vice 
versa for distal limb tendons (Huang et al., 2015). 
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Figure 1.2: Embryological Origin of Tendons in Vertebrates.  
Cranial tendons originate from neural crest cells (orange). Axial tendons originate from 
somites (purple). Appendicular tendons originate from LPM (green) (taken from Gaut & 
Duprez, 2016). 
 
  
Despite difference in the molecular programming of tendon formation across 
cranial, axial and appendicular skeletomusculature, research has proven that there are 
pathways that are ubiquitously expressed, particularly in regard to transforming growth 
factor beta (TGF-β). TGF-β induces Scx expression and is required for all tendon 
embryological development (Chen & Galloway, 2014; Havis et al., 2016; Pryce et al., 
2009). Furthermore, SMAD2 and SMAD3, which are downstream intracellular 
components within the TGF-β pathway, are required for proper Scx and Tenomodulin 
(Tnmd) expression in limb tendons (Havis et al., 2014; Shukunami et al., 2018).  Prior 
research suggest that once the tendon reaches its mature state, the homeobox protein, 
Mkx, may antagonize muscle differentiation to sustain the tendon fate of the cells (Liu et 
al., 2015). 
 After the generation of tendon progenitors, these tenoblasts will mature into 
tenocytes and form the extracellular infrastructure that comprises the majority of the 
tendon. In the embryo, tendon cells secrete collagen fibrils in an actin-dependent manner 
in longitudinal direction via membrane extensions, called fibripositors. During the post-
natal stages, the collagen fibrils expand in diameter and length to take on a bimodal 
distribution of 35-400 nm. This enlargement is responsible for the overall growth of the 
tendon into its mature state since the number of collagen fibrils and bundles remains 
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constant. Meanwhile, resident tendon cells maintain their cell-cell contact and transform 
from a rounded to stellate shape to increase surface area. 
 Several genetic markers have been identified to play key roles in the regulation of 
ECM formation in the developing tendon. The transmembrane glycoprotein Tnmd has 
been shown to be dependent on Scx expression to be involved in tendon cell proliferation 
and ECM formation (Shukunami et al., 2018). Other tendon matrix proteins, such as 
Col1a1, Cola2, Col3a1 and Col4a1, appear to be downstream targets of Scx signaling 
(Ezura et al., 2000). Additionally, Mkx and early growth response 1 (Egr1) have been 
implicated to be responsible for the tight regulation of ECM formation. Loss of Mkx 
reduces Tnmd, Fbmd and Dcn expression, while loss of Erg1 leads to lower levels of 
Col1a1, Col1a2, Col3a1, Col5a1, Col12a1, Col14a1, Tnmd, Fbmd, and Dcn (Guerquin et 
al., 2013; Ito et al., 2010). Several SLRPs, such as Dcn, Bgn, Fbmd and lumicans are also 
vital to ECM organization and normal collagen fibril growth (Grinstein & Galloway, 
2018).   
  
Identification of Tendon-Derived Stem/Progenitor Cells 
 Developing effective treatment options for tendon regeneration and repair remains 
to be problematic, due to a lack of understanding of the basic biology of the tendon, more 
specifically the tendon cell lineage and the properties that govern tendon cells and their 
precursors. Many prior studies have suggested the presence of multipotential stem cells, 
but a definitive stem cell or progenitor cell population in tendon tissue had not yet been 
isolated until fairly recently. 
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 In 2007, a study conducted by Bi et al were able to identify tendon stem 
cell/progenitor cells (TSPCs) as a unique tendon precursor cell population by running 
assays to analyze the differences between them and BMSCs in expression of several 
genetic markers, such as Scx, cartilage oligometric protein (Comp), Sox9, Runx2, Tnmd, 
BMP2, TGF-β1 and osterix (SP7). Once they confirmed these TSPCs as distinct, they 
placed them in osteogenic, adipocytic and chondrogenic media, to successfully induce 
differentiation into respective the cell type, which implicated that the TSPCs were 
multipotent. Then, they performed a transplantation assay to demonstrate that these cells 
could populate an immunocompromised host mouse as tendon-like tissue, which 
suggested that these cells possessed self-renewing capabilities. Collectively, these results 
implicated that these TSPCs were a unique, multipotent, self-renewing cell population. 
However, the identity of these TSPCs in the native tissue and their role in 
mediating injury repair remains relatively unclear, as the ambiguity of their name 
suggests. Previously established tendon markers, such as Scx, Col I and Mkx, appear to 
label all cells within the tendon (Edom‐Vovard & Duprez, 2004; Ito et al., 2010; 
Schweitzer et al., 2001). Since these studies do not provide much insight into the 
differential molecular expression of tendon cells nor the cellular heterogeneity of the 
tendon, a more specified marker may provide stronger evidence of the presence of a 
distinct tendon progenitor population. 
 
  12
Wnt Signaling and Role of Axin2 
 The Wnt pathway is a highly evolutionarily conserved molecular signal 
transduction cascade that serves as a fundamental regulatory mechanism for controlling 
stem cell growth, proliferation, differentiation and migration (Kaldis & Pagano, 2009; 
Nusse, 2008; Schambony & Wedlich, 2013). Wnt signaling also plays a key role in 
establishing body axes, forming tissues and inducting limbs, along with several other 
embryological processes (Amerongen & Nusse, 2009). Due to its extensive involvement 
in the regulation of stem cells, embryonic development and maintenance of adult organs, 
aberration of components within the Wnt signaling pathway has been implicated in the 
pathologies of many forms of cancer, congenital defects and degenerative diseases. 
 Wnt comprises a family of proteins that are secreted from cells as palmitoylated 
glycoproteins, which enables them to interact with the extracellular domain of a frizzled 
family receptor (Fz) located on a neighboring cell (paracrine signaling) or of its own 
through an autocrine mechanism.  There are three main types of Wnt signaling – the 
canonical pathway, noncanonical planar cell polarity pathway and noncanonical 
Wnt/calcium pathway – that are initiated by the association of distinct co-receptor 
proteins, such as lipoprotein receptor-related protein 5/6 (LRP5/6), receptor tyrosine 
kinase (RTK) and receptor tyrosine kinase like orphan receptor 2 (ROR2). 
 The canonical pathway, more commonly known as Wnt/β-Catenin signaling, is 
thought to be primarily responsible for changes in gene expression that control various 
cellular processes during embryonic development and tissue homeostasis. In the absence 
of Wnt induction, β-Catenin within the cytoplasm of the cell is constantly degraded 
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through the mediation of the Axin complex, which is formed by Axin, adenomatous 
polyposis coli (APC), casein kinase 1 (CK1) and glycogen synthase kinase 1 (GSK3). 
Phosphorylation of β-Catenin by CK1 and GSK3 allows β-TrCP, an E3 ubiquitin ligase 
subunit, to recognize β-Catenin and subsequent β-Catenin ubiquitination and proteasomal 
degradation. However, once Wnt interacts with the Fz receptor and the co-receptor 
LRP5/6, along with the recruitment of disheveled (Dvl), the Axin complex becomes 
inhibited. As a result, β-Catenin begins to accumulate in the cytoplasm and translocates 
into the nucleus to complex with a T-cell-specific transcription factor (Tcf) to activate 
gene targets of Wnt (MacDonald, Tamai, & He, 2009) (Figure 1.3). 
 
 
Figure 1.3: Model of Wnt Signaling Pathway 
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Axin2 is a downstream target of Wnt via direction induction by the β-catenin. Axin2 then 
serves as an inhibitor of Wnt through a negative feedback mechanism (taken from Jho et 
al., 2002).  
 
  
A more limitedly expressed homolog of Axin, called Axin2, has been identified as 
another important component of the canonical pathway. Axin2 is functionally similar to 
Axin in that they both serve as negative regulators of Wnt signaling and are 
interchangeable in the canonical Wnt pathway (Chia & Costantini, 2005). Axin2 is a 
direct target of Wnt/β-catenin, thereby creating a negative feedback loop (Jho et al., 
2002). Thus, Axin2 serves as an indicator of Wnt/β-catenin signaling since it is directly 
induced by β-catenin/Tcf complexes (Figure 1.3). 
  Previous studies have found Axin2-expressing stem cells in several organs, such 
as the intestine, liver, epidermis and brain, to be distinct populations involved in 
maintaining the self-renewing capabilities of these respective tissues (Bowman et al., 
2013; Lim et al., 2013; Wang et al., 2015). Therefore, given the limited knowledge on the 
mechanistic nature of TSPCs, this paper looks to explore using Axin2 as a marker to 
identify a subpopulation of tendon progenitor cells that may be utilizing Wnt/β-catenin 
signaling to facilitate regeneration and repair of the tendon after injury. By analyzing the 
growth rates, cell counts, FACS, and RT-qPCR for various tendon markers in Axin2+/- 
cells, this study aims to demonstrate that the tendon consists of a heterogenous progenitor 
population. Since isolation of these cells disrupts the tendon matrix, our analysis of 
Axin2+/- cell molecular response can be assumed to occur in an injured tendon state. 
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Therefore, these Axin2+ tendon cells may be a more specified progenitor population 
responsible for facilitating tendon regeneration and healing after injury. 
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METHODS 
 
Isolation of Tendon Progenitor Cells from Mice 
Tendon digest solution was prepared using 0.3% collagenase type II solution (3 
mg/ml) in Dulbecco’s modified eagle medium (DMEM) with 1:100 penicillin-
streptomycin (P/S) and 1:100 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
(HEPES). Mice were housed, maintained, and euthanized according to American 
Veterinary Medical Association guidelines. All experiments were performed according to 
the Massachusetts General Hospital Institutional Animal Care and Use Committee 
(IACUC: 2013N000062) approved protocol.  
Adult Axin2-CreERt2;Rosa-LSLTdTomato mice were given tamoxifen at 2-3 
months and were euthanized with 1 L/min CO2 exposure for 3 minutes and dissected to 
remove the Achilles tendons, and flexor and extensor tendons from each limb. The 
tendons from each limb were placed into Seal-Rite 2 ml microcentrifuge tubes 
containing 1 ml of the digest solution, and the tendons were cut with the dissecting 
scissors into smaller pieces. The samples in the 2 ml microcentrifuge tubes were 
incubated in a 37° C shaking water bath for at least 3 hours to activate the collagenase 
type II to remove extracellular matrix and separate fibers that comprise the tendon. 
Afterwards, 200 µl 0.2% collagenase type I and 300 µl 0.4% dispase were added to the 
samples in the 2 ml microcentrifuge tubes and incubated in the 37°  C shaking water bath 
for 30 minutes to further digest individual fibers.  
Meanwhile, a rinsing solution was prepared with 10% Fetal Bovine Serum (FBS) 
in Ham’s F10 Nutrient Mix containing 1:100 P/S and 1:100 HEPES. A 30 µm filter was 
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placed on top of new 2 ml microcentrifuge tubes and equilibrated with 500 µl of rinsing 
solution. Once the second digestion was complete, a 20 ml syringe with a 20G needle 
was used to draw and release the tendon slushy 5 times to dislodge the cells. Then, the 
cell suspension was filtered through the 30 µm filter. The samples were centrifuged at 
500 RCF for 5 minutes, followed by aspirating the supernatant down to 1 ml and 
resuspending the cell pellet with the 20 ml syringe and 20G needle. 5 ml round-bottom 
tubes, with a cap with a 35 µm nylon mesh, were equilibrated with 500 µl of rinsing 
solution and the cell suspension was filtered through the cap. The samples were 
centrifuged again at 500 RCF for 5 minutes. 
A six-well plate was prepared with 0.2% gelatin and incubated for at least 1 hour 
at 37° C. A tendon cell culture media was prepared with 10% FBS, 1% P/S and 1% 
HEPES in DMEM. The supernatant of the samples was aspirated down to 1 ml and the 
cells were resuspended with a P1000 micropipette. After aspirating off the gelatin from 
each well of the six-well plate, each sample was plated with 2 ml of the prepared tendon 
cell culture media and stored at 37° C. The following day, the cells were transferred to a 
10 cm culture plate with fresh tendon cell culture media for continued growth at 37° C for 
20 days for RT-qPCR analysis. Axin2+/- cells grown in co-culture were grown on the 
same 10 cm culture plate, while Axin2+/- cells grown in isolated culture were separated 
via flow cytometry prior to being plated on their own 10 cm culture plates. 
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FACS Analysis 
 Axin2+/- cells were sorted with FACS at 0 and 10 days after culture (DAC) for 
cell counting. Axin2+ cells were sorted for presence of stem cell marker SCA-1, 
fibroblast marker CD90.2, bovine mesenchymal stem cell (BMSC) marker CD44 and 
hematopoietic markers CD45 and CD31.  
Additionally, FACS was utilized at 0 DAC to separate Axin2+/- cells to grow in 
isolated culture and at 20 DAC for Axin2+/- cells grown in co-culture for RT-qPCR 
analysis. 
 
Determining Cell Count and Growth Rate of Axin2+/- Cells 
 Tendon cells were imaged under fluorescence microscopy at 4, 5, 7, 8, 9 and 10 
DAC. Using ImageJ, the Axin2+ cells (TdTomato-positive) and Axin2- cells (TdTomato-
negative) were counted in each image with dimensions of 1375x1037 pixels. The number 
of pixels comprising the 50 or 100 µm scale bar in each image was used to convert the 
dimensions of the image into µm2. Then, the number of cells per µm2 for each image was 
used to calculate the number of cells on the original 10 cm dish with surface area of 58.95 
cm2. Finally, the average cell count, standard deviation and growth rate for 4, 5, 7, 8, 9 
and 10 DAC were calculated using Microsoft Excel. 
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RNA Extraction from Axin2+/- Cells 
 A Zymo-Spin™ IIICG Column was prewashed with 400 µl RNA Wash Buffer, 
centrifuged for 30 seconds and the flow-through discarded. A DNase I Reaction Mix was 
prepared in an RNase-free tube by combining 5 µl of DNase with 75 µl of DNA 
Digestion Buffer. The 80 µl DNase I Reaction Mix was added directly to the column 
matrix and incubated at room temperature for 15 minutes, followed by being centrifuged 
for 30 seconds.  Meanwhile, 1 volume of 95-100% ethanol was added to each sample in 
RNA lysis buffer (1:1) and mixed well.  The mixture was transferred to the Zymo-Spin™ 
IIICG Column in a Collection Tube and centrifuged for 30 seconds, the flow-through 
discarded afterwards.   
400 µl of RNA Prep Buffer was added to the column, centrifuged for 30 seconds 
and the flow-through discarded. 700 µl of RNA Wash Buffer was added to the column, 
centrifuged for 30 seconds and the flow-through discarded. 400 µl of RNA Wash Buffer 
was added to the column and centrifuged for 2 minutes and the flow-through discarded. 
Afterwards, the column was transferred into an RNase-free tube. 100 µl of 
DNase/RNase-free water was added to the column matrix and centrifuged for 30 seconds 
to elute the RNA into the tube. The RNA was stored immediately at -70° C until further 
use. 
  20
 
Reverse Transcription 
 The RNA samples were diluted to 100 ng with double-distilled water (DDW). 1 
µl Oligo d(T)20 primer and 1 µl dNTP mix were added to each sample for a total of 13 µl. 
This annealing reaction was incubated for 5 minutes at 65° C and then placed on ice for 
at least 1 minute. Next, the reverse transcription reactions were prepared, along with a 
negative control, for each sample. For the RT reaction, 4 µl SuperScript™ IV buffer, 1 µl 
dithiothreitol (DTT), 1 µl RNase inhibitor and 1 µl SuperScript™ IV Reverse 
Transcriptase were added for a total of 20 µl. For the negative control, 1 µl DDW was 
used instead of SuperScript™ IV Reverse Transcriptase. The samples were incubated at 
55° C for 10 minutes, 80° C for 10 minutes and held at 12° C indefinitely. The newly 
synthesized cDNA was diluted to 1.25 ng/µl with DDW and stored at -20° C until further 
use. 
 
RT-qPCR Analysis of Axin2+/- Cells 
 A run mix for each gene of interest was prepared using 6.25 µl SYBR Green, 
0.1875 µl forward primer (20mM), 0.1875 µl reverse primer (20mM) and 4.875 µl DDW 
for a total of 11.5 µl per individual well. The following forward and reverse primers were 
used: 
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Gene of 
Interest 
F Primer (5’  3’) R Primer (5’  3’) 
Scx AAGTTGAGCAAAGACCGTGAC AGTGGCATCCACCTTCACTA 
Sox9 AGTACCCGCATCTGCACAAC TACTTGTAATCGGGGTGGTCT 
Col1a2 CCAGCGAAGAACTCATACAGC GGACACCCCTTCTACGTTGT 
Col3a1A TGACTGTCCCACGTAAGCAC GAGGGCCATAGCTGAACTGA 
Axin2 GACCGACGATTCCATGTCCA GCGGTGGGTTCTCGGAAAAT 
Mkx AGTGGCTTTACAAGCACCGT TTTGACACCTGCACTAGCGT 
Fbmd CATGGCAACCAGATTACC AGATATAAGGCCGTGAGG 
KI67 AGCAAGCCAACAGAATTTCCAG TATCTTGACCTTCCCCATCAGG 
CNX43 TTGACTTCAGCCTCCAAGG AATGAACAGCACCGACAGC 
Col2a1 CAGGGCTCCAATGATGTAGA TCTTCTGTGATCGGTACTCG 
Wnt3A GCGATGGCTCCTCTCGGATA AGCCAAGGACCACCAGATCG 
GAPDH TGTTCCTACCCCCAATGTGT GGTCCTCAGTGTAGCCCAAG 
Table 2.1: List of Forward and Reverse Primers 
 
 
The 11.5 µl run mix was plated into each well, followed by 1 µl of diluted cDNA 
containing 1.25 ng. Quadruplicates of each sample were plated on a LightCycler 480 
Multiwell Plate 384 as shown: 
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 Axin2+ 
Sample 1 
Axin2- 
Sample 1 
Axin2+ 
Sample 2 
Axin2- 
Sample 2 
Gene of 
Interest 
 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
Scx A 
                
Sox9 B 
                
Col1a2 C 
                
Col3a1A D 
                
Axin2 E 
                
Mkx F 
                
Fbmd G 
                
KI67 H 
                
CNX43 I 
                
Col2a1 J 
                
Wnt3A K 
                
GAPDH L 
                
-RT GAPDH M 
                
Table 2.1: LightCycler 480 Multiwell Plate 384 Set Up for RT-qPCR Experiments 
 
 
Each RT-qPCR experiment was ran on the LightCycler 480 Instrument II to yield 
results for further quantitative analysis using the ∆∆Ct method (Real-Time PCR 
Handbook, 2014). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) serves as the 
positive control and calibrator gene, while the -RT GAPDH represents the negative 
control.  
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RESULTS 
Determining Cell Count and Growth Rate of Axin2+/- Cells 
 TdTomato+ cells were sorted from adult Axin2-CreERt2;Rosa-LSLTdTomato 
mice that were given tamoxifen at 2-3 months of age. Previously unpublished work in the 
Galloway lab has determined that 9-15% of the Scx-GFP+ tendon cells were labeled by 
Axin2-CreERt2 and were TdTom+. These cells were isolated by FACS and cultured to 
compare their in vitro characteristics with the previously described TSPCs.  
Visual representation of the Axin2+/- tendon cells, via fluorescence imaging with 
TdTomato, suggests that Axin2+ cells proliferate at faster rates than the Axin2- cells 
(Figure 3.1).  
 
Figure 3.1: Fluorescence Microscopy Images of Axin2+ Cells in Co-Culture 
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The data accumulated from counting individual Axin2+/- cells with ImageJ from 
images taken at 4, 5, 7, 8, 9 and 10 DAC fortifies this belief as the Axin2+ cells were 
calculated to outnumber the Axin2- cells by a statistically significant amount (p ≤ 0.5) 
for 5, 7, 8, 9 and 10 DAC (Figure 3.2). 
 
Figure 3.2: Amount of Axin2+/- Cells After 10 Days in Co-Culture 
 
 
Furthermore, the growth rate of the Axin2+ cells between 4 to 5, 5 to 7 and 8 to 9 DAC 
were 25.38, 3.24 and 29.44 times faster than that of Axin2- cells, which was statistically 
significant (p ≤ 0.5) (Figure 3.3).  
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Figure 3.3: Daily Growth Rates of Axin2+/- Cells in Co-Culture 
 
 
More generally, the overall growth rate of Axin2+ cells from 4 to 10 DAC was calculated 
to be about 4.64 times faster than that of Axin2- cells, which was determined to be 
statistically significant (p ≤ 0.5) (Figure 3.4). 
 
Figure 3.4: Overall Growth Rate of Axin2+/- Cells in Co-Culture 
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FACS Analysis  
 FACS analysis between 0 and 10 DAC demonstrated a change in the tendon cell 
population from 90.2% Axin2- and 9% Axin2+ to 51.8% and 47%, respectively. 
Additionally, Axin2+ cells were largely positive for the stem cell marker SCA-1, 
fibroblast marker CD90.2 and surface receptor CD44 (Figure 3.5a). Meanwhile, Axin2+ 
cells were negative for surface receptors CD31 and CD45 (Figure 3.5b). 
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Figure 3.5: FACS Analysis Comparison Between Axin2+/- Cells 
(a) Tendon cell population shifts from primarily Axin2- to about half Axin2+ and half 
Axin2-. (b) Axin2+ cells are positive for CD44, CD90.2 and SCA-1 and are negative for 
CD31 and CD45. 
 
 
RT-qPCR Analysis of Axin2+/- Cells 
 RT-qPCR analysis of Axin2+/- cells after 20 days in isolated cultures revealed 
that Axin2+ cells expressed Mkx and Col II at significantly higher levels than Axin2- 
cells by 1.29 and 2.18 folds, respectively (p ≤ 0.5). Also, Axin2+ cells displayed Axin2 
at significantly higher levels than Axin2- cells at 6.04 folds, which confirms our ability to 
selectively isolate Axin2-expressing cells (Figure 3.6). 
 
Figure 3.5: Gene Expression of Axin2+/- Cells After 20 Days in Isolated Culture 
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DISCUSSION 
 
Confirming Potential of Axin2+ Cells as a Progenitor Population 
Prior research was able to further confirm the identity of TSPCs as a stem cell-
like population by demonstrating the presence of several markers (Bi et al., 2007). In 
light of these findings, we tested Axin2+ cells for the presence for the stem cell marker 
SCA-1, the BMSC marker CD44, the fibroblast marker CD90.2, the hematopoietic 
markers CD31 and CD45. The Axin2+ cells were similar to the TSPCs described in these 
prior findings, as they were positive for SCA-1, CD90.2 and CD44 and negative for 
CD31 and CD45 (Figure 3.5b). These findings implicate that the Axin2+ tendon cell 
population, indeed, is enriched for TSPCs and may possess stem cell and fibroblast-like 
qualities. However, further research must be conducted on measuring the self-renewing 
capacity of these cells in order for them to be confirmed as stem cells. 
 
 
Differences in Cell Count and Growth Rate Between Axin2+/- Cells 
Collectively, this data suggests Axin2+ cells possess a greater propensity to 
proliferate in response to disruption of the ECM than Axin2- cells. However, this is not 
without some major discrepancies in the data. The main issue with the data points to 
differences in the data collected from FACS analysis and the manual cell counting 
method using Image J. The calculations of cell count from ImageJ demonstrated that the 
Axin2+ cells outnumbered the Axin2- cells drastically after 10 DAC by over 30 million 
cells (Figure 3.2). Meanwhile, the FACS data, a more accurate measure, depicted a shift 
from 9% Axin2+ cells to 47% after 10 DAC (Figure 3.5a). The differences in these 
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results can be explained by several inherent human errors and systematic errors within 
the experimental design. 
Ultimately, the cell counting method using ImageJ illustrated the shortcomings of 
relying on a manual counting technique. Admittedly, taking pictures of the Axin2- cells 
proved to be a difficult task since they appeared to be more dispersed throughout the 
culture plate than the Axin2+ cells, which seemed to have more of a tendency to 
aggregate into colonies. Furthermore, it was naturally easier to view the Axin2+ cells 
with TdTomato in the images since they were marked with red fluorescence, while the 
Axin2- cells had no fluorescence and were more difficult to identify. Also, as the cells 
approached confluence, discerning individual cells became increasingly difficult. Overall, 
these errors likely skewed the counts in favor of Axin2+ cells and resulted in a much 
higher amount of Axin2+ cells. However, the data points towards an expansion in the 
Axin2+ cell population relative to the Axin2- cells. 
 In regard to the FACS methodology, the gates for identify Axin2-TdTom+ and 
Axin2-TdTom- were set conservatively, and the analysis did not include a large number 
of cells falling between the TdTom+/- gates. The gates were set in such a manner to 
ensure that only truly positive and negative tendon cells were accounted for in the FACS 
analysis. This method could have contributed to differences with the ImageJ analysis by 
cells not being counted in the flow cytometry data, but they were considered Axin2 
positive in our ImageJ analysis. In addition, our image-based counting method depends 
on exposure settings on the microscope, which may differ from those used in FACS.  
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Nevertheless, the fluorescence imaging and manual cell counting of Axin2+/- 
cells does elucidate differences in the general proliferation patterns of the two 
populations.  The Axin2+ cells appear to possess an exponential growth, while the 
Axin2- cells have a more linear growth rate over the course of the first 10 days in co-
culture (Figure 3.2 and 3.3). This, in fact, aligns with the FACS analysis since the total 
cell counts of both cell populations are greater on day 10 than they were on day 0 and 
there is a dramatic shift in the percentage of Axin2+ cells from 9% to 47% (figure 3.5). 
This suggests that Axin2+ cells have greater proliferative potential than Axin2- cells. 
Since Axin2+ is a downstream target and negative regulator of the Wnt/β-Catenin 
signaling pathway, it suggests that this pathway may be responsible for the proliferative 
capacity of these tendon precursor cells. 
 
Differential Gene Expression Between Axin2+/- Cells in Isolated Culture 
 RT-qPCR analysis of Axin2+/- cells, after being harvested from isolated culture 
after 20 days, demonstrated key differences in the gene expression between the two 
tendon cell populations that may provide insight into differences in how these cell 
populations behave and interact with one another. Axin2+ cells displayed a statistically 
significant upregulation in Col II and Mkx in comparison to Axin2- cells (p ≤ 0.5).  Prior 
research has suggested that Col II plays a role in the fibrocartilage and bone formation 
(Thomopoulos et al., 2002). However, since our research implicated upregulation of Col 
II when the tendon matrix is disrupted, it may also play a role in reestablishing the matrix 
in an injured tendon state as well.  
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Meanwhile, the finding of upregulation of Mkx in Axin2+ cells directly 
contradicts prior research that implicates Wnt/β-Catenin signaling in tendon-derived cells 
downregulates Mkx (Kishimoto et al., 2017). However, this can be explained by the 
apparent heterogeneity of the tendon cell population. Taking these new findings into 
account, the higher levels of Mkx may suggest that this Axin2+ cell  population may in 
fact be a more highly differentiated tendon progenitor cell since Mkx has been identified 
as a gene that maintains the tendon fate of resident cells (Ito et al., 2010). Furthermore, 
since Mkx has been suggested to be involved in regulating the formation of the ECM, an 
upregulation of this marker in Axin2+ cells further demonstrates their involvement in re-
establishing the tendon matrix (Ito et al., 2010). Alternatively, upregulation of Col II 
could suggest these cells are multipotent and capable of forming cartilage or bone in 
certain conditions. Previous studies have shown that tendon progenitor cells are capable 
of multilineage differentiation to bone or cartilage cell types in culture, and the tendon 
can form ectopic cartilage and bone under pathological conditions (J. Zhang et al., 2016) 
 
Concluding Remarks 
 This study has demonstrated, by utilizing Axin2 as a marker, that the cell 
population within the tendon appears to be heterogenous. Our data suggests that Axin2+ 
cells may be a subpopulation that possess more progenitor-like character than Axin2- 
cells since they demonstrate a faster growth rate and display higher gene expression 
levels indicative of being responsible for ECM formation in response to matrix 
disruption, which mimics the injured tendon state. Because Axin2 is a direct target of 
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Wnt/β-Catenin signaling and negatively regulates Wnt/β-Catenin signaling, our work 
implicates the canonical Wnt pathway in regulating tendon cell fate and controlling 
healing mechanisms of tendon. It is important to note that this study marks continued 
progress in uncovering the molecular mechanisms that underlie tendon biology, 
specifically regeneration and repair, but there remains a large gap in our understanding, 
which may be elucidated in future research focused on uncovering the function of Wnt/β-
Catenin signaling in regulating the Axin2+ cell population during tendon homeostasis 
and repair. Continuing to strive towards fully understanding the molecular properties of 
tendons in injury and repair remains a critical area of research and may aid in discovering 
cutting edge therapies for the various tendinopathies that impact so many.  
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